We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Karl Storz Acquires British AI Specialist Innersight Labs

By HospiMedica International staff writers
Posted on 11 Jan 2024
Print article
Image: KARL STORZ and Innersight Labs have combined forces to push AI solutions for healthcare (Photo courtesy of Business Wire)
Image: KARL STORZ and Innersight Labs have combined forces to push AI solutions for healthcare (Photo courtesy of Business Wire)

KARL STORZ (Tuttlingen, Germany), a family-owned MedTech company, has acquired Innersight Labs Ltd. (ISL, London, UK), an innovative software manufacturer for an undisclosed amount. Apart from state-of-the-art endoscopes, high-end medical devices, and integrated solutions for the operating room, KARL STORZ continues its expansion into innovative software solutions. The company’s wide customer base, which includes top-class physicians across the world, can now enjoy access to 3D models created from medical scans, making surgery much easier and even more successful. The know-how gained with the acquisition in the field of artificial intelligence (AI) will significantly enhance the KARL STORZ portfolio.

ISL has developed Innersight3D, a software-only product that allows surgeons to create a patient-specific 3D model from a medical CT or MRI scan. ISL labels the received scans according to different tissue types and creates an interactive 3D model. The three-dimensional representation can then be accessed and interacted with via a web link sent to the physician. Because of the more accurate preoperative assessment, benefits include for example reducing operation time and the risk of surgical complications. In comparison to competing products, ISL's AI-based algorithm can significantly reduce manual effort, lowering cost per model and time to deployment.

As part of the globally active KARL STORZ Group, ISL will now focus on commercial scaling and joint technology development. The ISL acquisition adds an AI product to the existing KARL STORZ portfolio marking the next step in its efforts to integrate AI into laparoscopic and robotic imaging solutions in the healthcare industry. KARL STORZ aims to incorporate the extensive possibilities offered by AI into the development of cutting-edge medical technology at an early stage, allowing it to offer the best instruments for patients with the highest safety standards in the market.

Related Links:
KARL STORZ
Innersight Labs Ltd.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Mechanical Baby Scale
seca 725

Print article

Channels

Surgical Techniques

view channel
Image: The device\'s LEDs light up in several colors, allowing surgeons to see which areas they need to operate on (Photo courtesy of UC San Diego)

Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons

During brain surgery, neurosurgeons need to identify and preserve regions responsible for critical functions while removing harmful tissue. Traditionally, neurosurgeons rely on a team of electrophysiologists,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.